GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.01B
Close$
$-140.29
299.8% downside
Current Fair Value
299.8% downsideOvervalued by 299.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.01 Billion |
|---|---|
| Enterprise Value | $2.12 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 1.97 |
| Outstanding Shares | 29,710,139 |
Return
| Return on Equity | -43.55% |
|---|---|
| Return on Assets | -22.09% |
| Return on Invested Capital | -16.55% |
Valuation & Multiples
| P/E Ratio | -18.5 |
|---|---|
| PEG | 7 |
| Price to Sales | 4.68 |
| Price to Book Ratio | 8.78 |
| Enterprise Value to Revenue | 4.65 |
| Enterprise Value to EBIT | -31.4 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$111.01 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.07
Average shareholder expectationRevenue Estimate
$122.93 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 35.41% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 108.26% |
|---|---|
| Total Invested | $63,119▼ 100.00% |
| Investors Holding | 4▼ 236.00% |
ESG Score
No data
About GeneDx Holdings Corp
3 employeesSema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...